Risk factors and outcomes associated with anastomotic leaks following esophagectomy: a systematic review and meta-analysis

SK Kamarajah, A Lin, T Tharmaraja… - Diseases of the …, 2020 - academic.oup.com
Anastomotic leaks (AL) are a major complication after esophagectomy. This meta-analysis
aimed to determine identify risks factors for AL (preoperative, intra-operative, and post …

Current status and application of proton therapy for esophageal cancer

X Wang, B Hobbs, SJ Gandhi, CT Muijs… - Radiotherapy and …, 2021 - Elsevier
Esophageal cancer remains one of the leading causes of death from cancer across the
world despite advances in multimodality therapy. Although early-stage disease can often be …

Geriatric Radiation Oncology: What We Know and What Can We Do Better?

F Roeder, AD Jensen, K Lindel, M Mattke… - … Interventions in Aging, 2023 - Taylor & Francis
Elderly patients represent a growing subgroup of cancer patients for whom the role of
radiation therapy is poorly defined. Older patients are still clearly underrepresented in …

Cardiotoxicity of radiation therapy in esophageal cancer

M Vošmik, M Hodek, D Buka… - Reports of Practical …, 2020 - journals.viamedica.pl
With a development of radiotherapeutic techniques, availability of radiotherapy data on
cardiotoxicity, and slowly improving esophageal cancer outcomes, an increasing emphasis …

A multi-institutional analysis of radiation dosimetric predictors of toxicity after trimodality therapy for esophageal cancer

A Garant, G Spears, D Routman, T Whitaker… - Practical radiation …, 2021 - Elsevier
Purpose This multi-institutional review explored associations between radiation dose-
volume histogram (DVH) parameters and cardiopulmonary toxicities with trimodality therapy …

Definitive chemoradiotherapy versus trimodality therapy for resectable oesophageal carcinoma: meta‐analyses and systematic review of literature

DM Voeten, CM den Bakker… - World journal of …, 2019 - Wiley Online Library
Background Standard therapy for loco‐regionally advanced, resectable oesophageal
carcinoma is trimodality therapy (TMT) consisting of neoadjuvant chemoradiotherapy and …

Executive summary of clinical and technical guidelines for esophageal cancer proton beam therapy from the Particle Therapy Co-Operative Group Thoracic and …

MD Chuong, CL Hallemeier, H Li, XR Zhu… - Frontiers in …, 2021 - frontiersin.org
Radiation therapy (RT) is an integral component of potentially curative management of
esophageal cancer (EC). However, RT can cause significant acute and late morbidity due to …

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis

H Lv, C Chao, B Wang, Z Wang, Y Qian… - Cancer …, 2021 - Wiley Online Library
Background The optimal treatment for elderly patients with esophageal cancer (EC) remains
controversial. In the present study, we aimed to investigate whether elderly patients with …

Patterns of care and outcomes of elderly esophageal cancer patients not meeting age-based criteria of the CROSS trial

V Verma, W Haque, D Zheng… - American Journal of …, 2019 - journals.lww.com
Objectives: The CROSS trial established neoadjuvant chemoradiation followed by surgery
(nCRT-S) as superior to surgery alone (S) for locally advanced esophageal cancer (EC) …

[HTML][HTML] The emerging role of proton therapy for esophagus cancer

KR Jethwa, MG Haddock, EJ Tryggestad… - Journal of …, 2020 - ncbi.nlm.nih.gov
Chemoradiotherapy (CRT) plays an essential role in the treatment of esophageal cancer as
either curative or neoadjuvant therapy. When delivered with conventional photon-based …